The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Genetic Architecture of Hsp90-Dependent Drug Resistance
Open accessAbstract
Hsp90 potentiates the evolution of azole resistance in the model yeast Saccharomyces cerevisiae and the opportunistic pathogen Candida albicans via calcineurin. Here, we explored effectors downstream of calcineurin regulating this Hsp90-dependent trait. Using S. cerevisiae erg3 mutants as a model, we determined that both Crz1 and Hph1 modulate azole resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A broad range of small molecules enhance antifungal activity in vitro and in vivo, with inhibitors of Hsp90, calcineurin, and TOR the most prominent among them 10,11 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Crz1 is the key mediator of calcineurin-dependent transcriptional responses [37],[41] and is implicated in tolerance to azoles in both S. cerevisiae and C. albicans [20],[42].”
From Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin (2009) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“there is increasing evidence of its regulatory role in azole resistance development.”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [163]
The cited source says what the claim attributes to it.
In the citing paper
“Hsp90 is involved in the folding of a diverse set of client proteins and the regulation of signal transduction pathways”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [163]
The cited source says what the claim attributes to it.
In the citing paper
“has been shown to potentiate the evolution of drug resistance traits, including some azole resistance mechanisms.”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [163]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483 · cited 1×
“Under physiological conditions, Hsp90 dynamically interacts with a diverse set of inherently unstable, or metastable, client proteins (20, 21, 28).”
BackgroundAntifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202 · cited 1×
“The azoles inhibit Erg11 and thereby block the biosynthesis of ergosterol, the predominant sterol of fungal membranes ( 17 ).”
BackgroundCellProfiler™: Free, Versatile Software for Automated Biological Image Analysis
Lamprecht, M. R., Sabatini, D. M., & Carpenter, A. E. (2007) · BioTechniques · doi:10.2144/000112257 · Cited by 895
Self-citationYoung, J. C., Moarefi, I., & Hartl, F. U. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104079 · Cited by 822
Heat-shock protein 90, a chaperone for folding and regulation
Picard, D. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012491 · Cited by 796 · cited 1×
“Under physiological conditions, Hsp90 dynamically interacts with a diverse set of inherently unstable, or metastable, client proteins ( 20 , 21, 28).”
BackgroundHsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · cited 7×
“In fungi separated by 800 million years of evolution, we found that Hsp90 potentiates the rapid evolution of drug resistance (7).”
BackgroundInfluentialSelf-citationYoshimoto, H., Saltsman, K., Gasch, A. P., Li, H. X., Ogawa, N., Botstein, D., Brown, P. O., & Cyert, M. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202718200 · Cited by 404 · cited 2×
“In S. cerevisiae, azoles stimulate Ca2 influx, activating calcium signaling pathways and upregulating genes controlled by Crz1 (4, 9). While Crz1 mediates most Ca2- and Nainduced calcineurin-dependent gene expression (13, 27 ), cells lacking Crz1 function are less sensitive to alkaline pH or to high salt concentration…”
BackgroundSanglard, D., Ischer, F., Parkinson, T., Falconer, D., & Bille, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2404-2412.2003 · Cited by 398 · cited 1×
“The cellular circuitry underlying erg3-mediated resistance is of particular interest as azole-resistant clinical isolates of C. albicans harboring this resistance mechanism have been recovered from patients treated with azoles ( 23 ).”
BackgroundEvolution of antifungal-drug resistance: mechanisms and pathogen fitness
Anderson, J. B. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1179 · Cited by 375 · cited 2×
“This resistance mechanism blocks the accumulation of toxic sterol intermediates, resulting in altered membrane sterol composition ( 1 ).”
BackgroundSanglard, D., Ischer, F., Marchetti, O., Entenza, J., & Bille, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03495.x · Cited by 350 · cited 1×
“Calcineurin activation is required for tolerance of a myriad of environmental stresses, including the membrane stress exerted by azoles (8, 22).”
Background
Cited by
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Carpenter, A. E., Jones, T. R., Lamprecht, M. R., Clarke, C., Kang, I. H., Friman, O., Guertin, D. A., Chang, J. H., Lindquist, R. A., Moffat, J., et al. (2006) · Genome Biology · doi:10.1186/gb-2006-7-10-r100 · Cited by 5,157
Self-citationMechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
“Inhibition of Hsp90 can also block the evolution of azole resistance, and abrogate resistance caused by the loss of function of Erg3 or resistance that evolved in a human host by multiple mechanisms (Cowen and Lindquist 2005; Cowen et al. 2006).”
BackgroundSelf-citationVerghese, J., Abrams, J., Wang, Y., & Morano, K. A. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05018-11 · Cited by 575
“phatase calcineurin, providing a molecular mechanism (73).”
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
“albicans and that the inhibition of Hsp90 blocks this activation (536), consistent with calcineurin being a key mediator of Hsp90-dependent azole resistance (113, 115).”
BackgroundInfluentialSelf-citationSionov, E., Lee, H., Chang, Y. C., & Kwon-Chung, K. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000848 · Cited by 479
“Hsp90 that may facilitate the cells to respond to drug stress [21,22].”
BackgroundDispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle
Uppuluri, P., Chaturvedi, A. K., Srinivasan, A., Banerjee, M., Ramasubramaniam, A. K., Köhler, J. R., Kadosh, D., & Lopez-Ribot, J. L. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000828 · Cited by 432
“More importantly, in combination with fluconazole, GDA is fungistatic in planktonic cells [69,70].”
BackgroundCowen, L. E., Singh, S. D., Köhler, J. R., Collins, C., Zaas, A. K., Schell, W. A., Aziz, H., Mylonakis, E., Perfect, J. R., Whitesell, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813394106 · Cited by 413
“Pharmacological inhibition of Hsp90 blocks the emergence of azole resistance and abrogates resistance of laboratory mutants and strains that evolved resistance in a human host (14, 15).”
BackgroundInfluentialSelf-citationHsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000532 · Cited by 362
“The key mediator of Hsp90-dependent azole resistance is calcineurin, a protein phosphatase that regulates crucial responses to environmental stress, including the membrane stress exerted by exposure to azoles [20,21].”
BackgroundMethodInfluentialSelf-citationLaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329
“For reference, we included a strain lacking the regulatory subunit of calcineurin, CNB1, which is hypersensitive to ergosterol biosynthesis inhibitors [24].”
BackgroundInfluentialSelf-citationHarnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
Steinbach, W. J., Reedy, J. L., Cramer, R. A., Perfect, J. R., & Heitman, J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1680 · Cited by 313
The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
Cowen, L. E. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1835 · Cited by 311
“Recent studies have revealed that an evolutionarily conserved mechanism of protein folding can modulate the phenotypic consequences of mutations that confer antifungal drug resistanc”
BackgroundSelf-citationHsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291
“The finding that compromise of calcineurin function does not confer as severe a reduction in biofilm fluconazole resistance as compromise of Hsp90 function is intriguing in light of the fact that under all planktonic conditions tested, inhibition of calcineurin phenocopies inhibition of Hsp90 in terms of azole resista…”
BackgroundSelf-citationRosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285
“Hsp90 inhibitors also reduce the resistance of Erg3 loss-of-function mutants and clinical isolates that have acquired resistance by multiple mechanisms (34, 36).”
BackgroundSelf-citationCurrent Perspectives on Echinocandin Class Drugs
Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.19 · Cited by 274
“This Ca2+/calmodulin-dependent serine threonine phosphatase helps regulate responses to membrane stress in yeasts and moulds [108,110].”
BackgroundAntifungal Drugs: The Current Armamentarium and Development of New Agents
Robbins, N., Wright, G. D., & Cowen, L. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0002-2016 · Cited by 271
“Pharmacological inhibition of calcineurin in C. neo-formans abrogates growth at 37°C (78), potentiates the activity of both azoles and echinocandins in C. albicans (79 – 83), and renders the fungistatic azoles fungicidal against multiple Candida species (84).”
BackgroundSelf-citationCombinatorial strategies for combating invasive fungal infections
Spitzer, M., Robbins, N., & Wright, G. D. (2017) · Virulence · doi:10.1080/21505594.2016.1196300 · Cited by 218
Candida albicans drug resistance—Another way to cope with stress
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Tanabe, K., Niimi, M., & Monk, B. C. (2007) · Microbiology · doi:10.1099/mic.0.2007/010405-0 · Cited by 208
“In vitro studies have also demonstrated a role for Hsp90, a molecular chaperone for calcineurin, in promoting the rapid acquisition of fluconazole resistance by C. albicans (Cowen & Lindquist, 2005; Cowen et al., 2006).”
BackgroundPost-translational modifications of Hsp90 and translating the chaperone code
Backe, S. J., Sager, R. A., Woodford, M. R., Makedon, A. M., & Mollapour, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011833 · Cited by 205
“In fungi, particularly in pathogenic species, fungal Hsp90 mediates resistance to anti-fungals, such as azoles, by enabling resistance mutations and stabilizing resistance-mediating protein products (203, 204).”
BackgroundGlobal Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 205
Self-citationSionov, E., Chang, Y. C., Garraffo, H. M., & Kwon-Chung, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-09 · Cited by 179
Schumacher, J., Fernandez-de-Larrinoa, Í., & Tudzynski, B. (2008) · Eukaryotic Cell · doi:10.1128/ec.00426-07 · Cited by 179
“albicans have elucidated a role for calcineurin signaling in response to membrane stress caused by detergents and antifungal azoles, such as fluconazole (4, 10, 11, 17, 34, 49, 58).”
BackgroundCalcineurin-Crz1 Signaling in Lower Eukaryotes
Thewes, S. (2014) · Eukaryotic Cell · doi:10.1128/ec.00038-14 · Cited by 166
“cerevisisae crz1 strains are hypersensitive to fluconazole, miconazole, and terbinafine (36, 75).”
BackgroundMolecular Chaperones in Pathogen Virulence: Emerging New Targets for Therapy
Neckers, L., & Tatu, U. S. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.10.011 · Cited by 146
Heat Shock Protein 90 Is Required for Conidiation and Cell Wall Integrity in Aspergillus fumigatus
Lamoth, F., Juvvadi, P. R., Fortwendel, J. R., & Steinbach, W. J. (2012) · Eukaryotic Cell · doi:10.1128/ec.00032-12 · Cited by 136
“albicans was shown to be mediated by the calcineurin pathway (7, 8, 31).”
Hsp90 orchestrates stress response signaling governing fungal drug resistance
Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000471 · Cited by 130
“Crz1 plays a partial role in azole tolerance in both yeast species [15,16] and it also plays a partial role in echinocandin tolerance in C.”
Self-citationLysine Deacetylases Hda1 and Rpd3 Regulate Hsp90 Function thereby Governing Fungal Drug Resistance
Robbins, N., Leach, M. D., & Cowen, L. E. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.035 · Cited by 126
“cerevisiae erg3 loss-of-function mutants, concordantwith the impact ofHsp90 inhibition (Figure 1C;Cowen et al., 2006;CowenandLindquist, 2005; LaFayette et al., 2010).”
BackgroundInfluentialSelf-citationJuvvadi, P. R., Lamoth, F., & Steinbach, W. J. (2014) · Fungal Biology Reviews · doi:10.1016/j.fbr.2014.02.004 · Cited by 116
“Hsp90 was shown to have a key role in the acquisition and evolution of resistance to azoles and echinocandins, and growing evidence suggests that this inherent resistance mechanism is mediated via calcineurin (Cowen et al., 2006; Cowen and Lindquist, 2005; Cowen et al., 2009; Singh et al., 2009).”
BackgroundInfluentialPlasmodial heat shock proteins: targets for chemotherapy
Shonhai, A. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00639.x · Cited by 127
“Activation of calcineurin is known to promote resistance to stress in yeast (Cruz et al., 2002), and by modulating calcineurin function, Hsp90 was able to enhance resistance to azole antifungal drugs in Saccharomyces cerevisiae (Cowen et al., 2006).”
BackgroundFungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs
Leach, M. D., Klipp, E., Cowen, L. E., & Brown, A. J. P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2875 · Cited by 107
Self-citationIt’s not magic – Hsp90 and its effects on genetic and epigenetic variation
Zabinsky, R. A., Mason, G. A., Queitsch, C., & Jarosz, D. F. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.015 · Cited by 118
Nishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Gong, Y., Li, T., Yu, C., & Sun, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00520 · Cited by 114
Elucidating Drug Resistance in Human Fungal Pathogens
Xie, J. L., Polvi, E. J., Shekhar‐Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 127
Self-citationpH Signaling in Human Fungal Pathogens: a New Target for Antifungal Strategies
Cornet, M., & Gaillardin, C. M. (2014) · Eukaryotic Cell · doi:10.1128/ec.00313-13 · Cited by 110
Selection Transforms the Landscape of Genetic Variation Interacting with Hsp90
Geiler‐Samerotte, K., Zhu, Y. O., Goulet‐Scott, B. E., Hall, D. W., & Siegal, M. L. (2016) · PLoS Biology · doi:10.1371/journal.pbio.2000465 · Cited by 100
Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations
Hill, J. A., Ammar, R., Torti, D., Nislow, C., & Cowen, L. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003390 · Cited by 93
“Inhibition of Hsp90 or calcineurin with molecules that are well tolerated in humans can impair the evolution of azole resistance [16,20], though the potential for evolution of resistance to the drug combinations remains unknown.”
BackgroundSelf-citationThe fungal Achilles’ heel: targeting Hsp90 to cripple fungal pathogens
Cowen, L. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.005 · Cited by 104
Self-citationCalcineurin Regulation in Fungi and Beyond
Stie, J., & Fox, D. S. (2007) · Eukaryotic Cell · doi:10.1128/ec.00326-07 · Cited by 99
The role of Candida albicans stress response pathways in antifungal tolerance and resistance
Iyer, K. R., Robbins, N., & Cowen, L. E. (2022) · iScience · doi:10.1016/j.isci.2022.103953 · Cited by 88
“When activated, this initiates a signaling cascade leading to the dephosphorylation and activation of themajor transcription factor Crz1, as well as other factor(s) remaining to be identified (Figure 1) (Cowen et al., 2006; Singh et al., 2009).”
BackgroundSelf-citationUsing CellProfiler for Automatic Identification and Measurement of Biological Objects in Images
Vokes, M. S., & Carpenter, A. E. (2008) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1417s82 · Cited by 87
“…microarray annotation, yeast patch assays, cell-cycle classification, mouse tumor quantification, wound healing assays, and tissue topology measurement (Cowen et al., 2006; Hartwell et al., 2006; Lamprecht et al., 2007), as well as analysis of fluorescence microscopy images for measurement of cell…”
MethodSelf-citationDrug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis
Murphy, S. E., & Bicanic, T. A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.759408 · Cited by 100
Antifungal activity of redox-active benzaldehydes that target cellular antioxidation
Jong Heon, K. I. M., Chan, K. L., Mahoney, N. E., & Campbell, B. C. (2011) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-10-23 · Cited by 83
“Involvement of stress-inducible protein(s) in drug resistance has already been documented [67,68].”
BackgroundSingh, B. N., Upreti, D. K., Singh, B. R., Pandey, G., Verma, S., Roy, S., Naqvi, A. H., & Rawat, A. K. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03599-14 · Cited by 84
Harmine Is a Potent Antimalarial Targeting Hsp90 and Synergizes with Chloroquine and Artemisinin
Shahinas, D., MacMullin, G., Benedict, C., Crandall, I., & Pillai, D. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00328-12 · Cited by 74
Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 77
Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans
Angiolella, L., Stringaro, A., Bernardis, F. D., Posteraro, B., Bonito, M., Toccacieli, L., Torosantucci, A., Colone, M., Sanguinetti, M., Cassone, A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01223-07 · Cited by 75
“evolution in Candida and, particularly, its relevance for fungus fitness in vitro (9, 11), very little is known about the potential consequences of ADR acquisition on virulence expression in vitro and in vivo.”
BackgroundLamoth, F., Juvvadi, P. R., Gehrke, C., Asfaw, Y. G., & Steinbach, W. J. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit530 · Cited by 62
“albicans [4, 5, 35] was not obvious in our work on A.”
BackgroundDudgeon, D. D., Zhang, N., Ositelu, O. O., Kim, H., & Cunningham, K. W. (2008) · Eukaryotic Cell · doi:10.1128/ec.00291-08 · Cited by 59
“cineurin function (14), inhibitors of Hsp90 did not mimic in-”
BackgroundInfluentialChatterjee, S., & Tatu, U. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005836 · Cited by 57
Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus
Lamoth, F., Juvvadi, P. R., & Steinbach, W. J. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.947239 · Cited by 81
“For instance, we did not recover calcineurin, a well-known regulator of fungal stress responses and virulence that was demonstrated to functionally and physically interact with Hsp90 in yeasts (Cowen & Lindquist, 2005; Cowen et al., 2006; Imai & Yahara, 2000; Singh et al., 2009).”
BackgroundKim, J., Cho, Y.-J., Do, E., Choi, J., Hu, G., Cadieux, B., Chun, J., Lee, Y., Kronstad, J. W., & Jung, W. H. (2012) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2012.08.006 · Cited by 53
Delavy, M., Cerutti, L., Croxatto, A., Prod’hom, G., Sanglard, D., Greub, G., & Coste, A. T. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03000 · Cited by 62
“Previous studies effectively shown that calcineurin is involved in tolerance but also resistance through the Pkc1 and TOR pathways (Cowen et al., 2006; LaFayette et al., 2010; Robbins et al., 2010).”
BackgroundAntifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 65
“In addition, inhibition of HSP90 can block the evolution of azole resistance caused by the loss of function of ERG3 [118].”
BackgroundEfungumab and caspofungin: pre-clinical data supporting synergy.
Hodgetts, S., Nooney, L., Al-Akeel, R., Curry, A., Awad, S., Matthews, R., & Burnie, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn075 · Cited by 51
“Hsp90 binds to the catalytic subunit of calcineurin, keeping it stable and poised for activation.(34) These data will form the scientific basis for a clinical study examining the hypothesis that the addition of efungumab to caspofungin therapy will improve outcome in invasive candidiasis similar to the improvement see…”
BackgroundMolecular bases of antifungal resistance in filamentous fungi
Sharma, C., & Chowdhary, A. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.06.018 · Cited by 55
Antifungal resistance in Aspergillus terreus: A current scenario
Vahedi‐Shahandashti, R., & Lass‐Flörl, C. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103247 · Cited by 54
O'Meara, T. R., & Cowen, L. E. (2014) · Cellular Microbiology · doi:10.1111/cmi.12266 · Cited by 48
“…such as the protein phosphatase calcineurin or elements of the protein kinase C (PKC) pathway, Hsp90 enables the phenotypic effects of resistance mutations, and thus the development of drug resistance (Cowen and Lindquist, 2005; Cowen et al., 2006; Singh et al., 2009; Singh-Babak et al., 2012).”
BackgroundSelf-citationCalcium-calcineurin signaling pathway in Candida albicans: A potential drug target
Li, W., Shrivastava, M., Lu, H., & Jiang, Y. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126786 · Cited by 47
Azole resistance in Aspergillus fumigatus- comprehensive review
Dladla, M., Gyzenhout, M., Marais, G. J., & Ghosh, S. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04026-z · Cited by 49
“A calcium and calmodulin-dependent protein phosphatase, calcineurin, is a key mediator of Hsp90-dependent azole resistance and is involved in the regulation of crucial environmental stress responses, including azole-exerted stresses on a cell membrane (Cowen and Lindquist 2005 ; Cowen et al. 2006 ).”
Lee, H., Lamichhane, A. K., Garraffo, H. M., Kwon-Chung, K. J., & Chang, Y. C. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08016.x · Cited by 53
“This article is a U.S. Government work and is in the public domain in the USA. to drug stress (Cowen and Lindquist, 2005; Cowen et al., 2006).”
Naderer, T., Dandash, O., & McConville, M. J. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07584.x · Cited by 53
“For example, HSP90 regulates calcineurin function in other eukaryotes (Cowen et al., 2006) and appears to play a key role in promastigote to amastigote differentiation in Leishmania (Wiesgigl and Clos, 2001).”
BackgroundReassessing the Use of Undecanoic Acid as a Therapeutic Strategy for Treating Fungal Infections
Rossi, A., Martins, M. P., Bitencourt, T. A., Peres, N. T. A., Rocha, C. H. L., Rocha, F. M. G., Neves‐da‐Rocha, J., Lopes, M. E. R., Sanches, P. R., Bortolossi, J. C., et al. (2021) · Mycopathologia · doi:10.1007/s11046-021-00550-4 · Cited by 51
“Events of environmentally induced resistance occurring before genetic resistance are well described and pose a real challenge for antifungal therapy [67, 68].”
BackgroundJia, X. M., Wang, Y., Jia, Y., Gao, P. H., Xu, Y. G., Wang, L., Cao, Y. Y., Cao, Y. B., Zhang, L. X., & Jiang, Y. Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8409-3 · Cited by 45
Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance
Shahinas, D., Folefoc, A., & Pillai, D. R. (2013) · Pathogens · doi:10.3390/pathogens2010033 · Cited by 55
“It provides a compensatory regulatory mechanism that maintains the functional conformation of regulatory proteins, including many that are involved in drug resistance [47,48,54,55].”
BackgroundProgress and prospects for targeting Hsp90 to treat fungal infections
Veri, A. O., & Cowen, L. E. (2014) · Parasitology · doi:10.1017/s0031182013002072 · Cited by 49
“In C. albicans, the first Hsp90 client protein identified was calcineurin (Cowen and Lindquist, 2005; Cowen et al. 2006; Singh et al. 2009), a serine threonine protein phosphatase and key regulator of resistance to azoles and echinocandins (Cruz et al. 2002; Sanglard et al. 2003; Singh et al. 2009).”
BackgroundResultSelf-citationLi, X., Robbins, N., O’Meara, T. R., & Cowen, L. E. (2016) · Molecular Microbiology · doi:10.1111/mmi.13578 · Cited by 53
“For both S. cerevisiae and C. albicans, resistance to the azoles acquired by loss of function of the ergosterol biosynthetic enzyme Erg3 is highly dependent on both Hsp90 and KDAC function (Cowen and Lindquist, 2005; Cowen et al., 2006; LaFayette et al., 2010; Robbins et al., 2012).”
BackgroundSelf-citationLi, X., Yu, C., Huang, X., & Sun, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168936 · Cited by 44
Can Saccharomyces cerevisiae keep up as a model system in fungal azole susceptibility research?
Demuyser, L., & Dijck, P. V. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.02.002 · Cited by 46
The heat shock proteins: Their roles as multi-component machines for protein folding
Panaretou, B., & Zhai, C. (2008) · Fungal Biology Reviews · doi:10.1016/j.fbr.2009.04.002 · Cited by 50
Jarosz, D. F. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.11.001 · Cited by 43
Decanalizing thinking on genetic canalization
Geiler‐Samerotte, K., Sartori, F. M. O., & Siegal, M. L. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.008 · Cited by 42
“Loss-of-function mutations in genes encoding proteins downstream of Hsp90 in the stress response network, such as Crz1 and Hph1/Hph2, impair the anti-fungal resistance of erg3 mutants to varying degrees in different yeast strains [62].”
BackgroundEmerging Mechanisms of Drug Resistance in Candida albicans
Prasad, R., Nair, R., & Banerjee, A. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_6 · Cited by 45
Novel Antifungal Agents and Their Activity against Aspergillus Species
Vahedi‐Shahandashti, R., & Lass‐Flörl, C. (2020) · Journal of Fungi · doi:10.3390/jof6040213 · Cited by 51
Chen, S. C.-A., Lewis, R. E., & Kontoyiannis, D. P. (2011) · Virulence · doi:10.4161/viru.2.4.16764 · Cited by 41
A Purine Analog Synergizes with Chloroquine (CQ) by Targeting Plasmodium falciparum Hsp90 (PfHsp90)
Shahinas, D., Folefoc, A., Taldone, T., Chiosis, G., Crandall, I., & Pillai, D. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075446 · Cited by 41
“Infection, transformation and neurodegeneration are all characterized by abnormal cell signaling, altered levels of expression and different protein interactions in the cell [8–15] and as such, Hsp90 has been identified as a target for infections [2–4,16,17], cancer [10,11,18– 22] and Alzheimer’s disease [8,9].”
BackgroundMethodInfluentialEvolutionary divergence in the fungal response to fluconazole revealed by soft clustering
Kuo, D., Tan, K., Zinman, G., Ravasi, T., Bar‐Joseph, Z., & Ideker, T. (2010) · Genome biology · doi:10.1186/gb-2010-11-7-r77 · Cited by 41
“Other studies have focused on cultures for which drug resistance has been artificially evolved in-vitro [15,18,20,21].”
InfluentialPotential Microbiological Effects of Higher Dosing of Echinocandins
Steinbach, W. J., Lamoth, F., & Juvvadi, P. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ725 · Cited by 48
Mount, H. O., Revie, N. M., Todd, R. T., Anstett, K., Collins, C., Costanzo, M., Boone, C., Robbins, N., Selmecki, A., & Cowen, L. E. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007319 · Cited by 34
Self-citationMetabolic control of antifungal drug resistance
Robbins, N., Collins, C., Morhayim, J., & Cowen, L. E. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.07.004 · Cited by 40
Self-citationRegulatory roles of phosphorylation in model and pathogenic fungi
Bataineh, M. T. A., & Kadosh, D. (2015) · Medical Mycology · doi:10.1093/mmy/myv098 · Cited by 38
Potentiation of Azole Antifungals by 2-Adamantanamine
LaFleur, M. D., Sun, L., Lister, I., Keating, J., Nantel, A., Long, L. A., Ghannoum, M. A., North, J., Lee, R. E., Jr., Coleman, K., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00294-13 · Cited by 37
Kim, S. W., Hasanuzzaman, M., Cho, M., Heo, Y. R., Ryu, M., Ha, N.-Y., Park, H. J., Park, H., & Shin, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624106 · Cited by 34
Signaling cascades as drug targets in model and pathogenic fungi.
Bastidas, R. J., Reedy, J. L., Morales-Johansson, H., Heitman, J., & Cardenas, M. E. (2008) · PubMed · Cited by 46
Alves, R. M. A., Kastora, S. L., Gomes-Gonçalves, A., Azevedo, N. F., Rodrigues, C. F., Silva, S. M., Demuyser, L., Dijck, P. V., Casal, M., Brown, A. J. P., et al. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-0114-5 · Cited by 34
Structure-guided approaches to targeting stress responses in human fungal pathogens
LeBlanc, E. V., Polvi, E. J., Veri, A. O., Privé, G. G., & Cowen, L. E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.013731 · Cited by 35
“In diverse fungi, Hsp90 regulates responses to stress induced by antifungal drugs and enables the evolution of drug resistance by stabilizing core components of stress responses, including the protein phosphatase calcineurin and multiple kinases in the Pkc1 mitogen-activated protein kinase cell wall integrity pathway…”
BackgroundSelf-citationWang, H., Sun, M., Guo, J., Ma, L., Jiang, H., Gu, L., Wen, H., Liao, S., Chen, J., Zeng, B., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.007 · Cited by 27
A Review of Recent Patents on the Protozoan Parasite HSP90 as a Drug Target
Angel, S. O., Matrajt, M., & Echeverría, P. C. (2013) · Recent Patents on Biotechnology · doi:10.2174/1872208311307010002 · Cited by 27
Robbins, N., & Cowen, L. E. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.071 · Cited by 24
Self-citationAntifungal adjuvants: Preserving and extending the antifungal arsenal
Butts, A., Palmer, G. E., & Rogers, P. D. (2016) · Virulence · doi:10.1080/21505594.2016.1216283 · Cited by 29
“Recently, it has been shown that depletion of Hsp90 interferes with the development of resistance to azoles and echinocandins.(45,46) As such, inhibition of Hsp90 by the natural product geldanamycin and synthetic analogs, 17-(dimethylaminoethylamino)-”
BackgroundThe Hsp90 Co-chaperones Sti1, Aha1, and P23 Regulate Adaptive Responses to Antifungal Azoles
Gu, X., Xue, W., Yin, Y., Liu, H., Li, S., & Sun, X. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01571 · Cited by 26
“Intensive studies have been done to understand how Hsp90 mediates azole resistance in Saccharomyces cerevisiae, the yeast-like fungus C. albicans, and the filamentous fungus A. fumigatus (Cowen and Lindquist, 2005; Cowen et al., 2006; Cowen, 2009).”
Antifungal Drugs: The Current Armamentarium and Development of New Agents
Robbins, N., Wright, G. D., & Cowen, L. E. (2017) · ASM Press eBooks · doi:10.1128/9781555819583.ch44 · Cited by 27
Self-citationNagao, J.-I., Cho, T., Uno, J., Ueno, K., Imayoshi, R., Nakayama, H., Chibana, H., & Kaminishi, H. (2012) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2012.00822.x · Cited by 30
“As reported by Cowen et al. (2006), both inhibitors enhanced fluconazole susceptibility of the two strains.”
BackgroundThe non-Geldanamycin Hsp90 inhibitors enhanced the antifungal activity of fluconazole.
Li, L., An, M., Shen, H., Huang, X., Yao, X., Liu, J., Zhu, F., Zhang, S., Chen, S., He, L., et al. (2015) · PubMed · Cited by 33
Screening Cellular Feature Measurements for Image-Based Assay Development
Logan, D. J., & Carpenter, A. E. (2010) · SLAS DISCOVERY · doi:10.1177/1087057110370895 · Cited by 24
“Flexible, modular software is needed for this purpose; CellProfiler meets these criteria by offering the use of numerous algorithms and optional settings, and it measures a large number of features, including the size and shape of each cell and subcellular compartment, as well as the intensity and texture of each stai…”
InfluentialSelf-citationMatos, T. G. F., Morais, F. V., & de Campos, C. B. L. (2012) · Medical Mycology · doi:10.3109/13693786.2012.725481 · Cited by 23
Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates
Alabi, P., Gautier, C., Murphy, T. P., Gu, X., Lepas, M., Aimanianda, V., Sello, J. K., & Ene, I. V. (2023) · mBio · doi:10.1128/mbio.00479-23 · Cited by 30
Malavazi, I., Ferreira, M. E. D. S., Soriani, F. M., Dinamarco, T. M., Savoldi, M., Uyemura, S. A., Goldman, M. H. S., & Goldman, G. H. (2009) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.06.009 · Cited by 24
“Calcineurin is not only required for azole resistance mediated by loss of function of Erg3 but also for resistance due to multiple mechanisms found in clinical isolates (Cowen et al., 2006; Cowen and Lindquist, 2005; Cowen and Steinbach, 2008).”
BackgroundAntifungal resistance, combinations and pipeline: oh my!
Stover, K. R., Hawkins, B. K., Keck, J. M., Barber, K. E., & Cretella, D. A. (2023) · Drugs in Context · doi:10.7573/dic.2023-7-1 · Cited by 22
Metadata
- Authors
- Cowen, L. E., Carpenter, A. E., Matangkasombut, O., Fink, G. R., & Lindquist, S.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Chulalongkorn University (TH)
- Venue
- Eukaryotic Cell
- Publisher
- American Society for Microbiology
- Published
- 2006-12
- Volume
- 5
- Issue
- 12
- Pages
- 2184-2188
- ISSN
- 1535-9778 (ISSN-L)
- 1535-9786
- PMC
- PMC1694807
- OpenAlex
- W2135342672
- Cited by
- 159
- References
- 28
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 8 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 11 · 2015: 10 · 2014: 12 · 2013: 9 · 2012: 14
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Eukaryotic Cell (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- Alexander and Margaret Stewart Trust
- Life Sciences Research Foundation
- National Institute of Environmental Health Sciences (P30ES002109, P30ES-02109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- HSP90, azole resistance, calcineurin, Candida albicans, Saccharomyces cerevisiae, Crz1, drug resistance, genetic architecture, effector proteins
- MeSH terms
- Antifungal Agents, Genes, Fungal, Mutation, Oxidoreductases, Saccharomyces cerevisiae, Fluconazole, HSP90 Heat-Shock Proteins, Calcineurin, Drug Resistance, Fungal, Saccharomyces cerevisiae Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.